German multinational engineering and electronics company Bosch, is ready to invest in Iran’s pharmaceutical industry.
The representative of Bosch Pharmaceutical Ltd and company’s general manager for Africa and Middle East, Mazen Touban, met top Health Ministry officials, Mohsen Asadi-Lari, director-general for international affairs and Rasoul Dinarvand, deputy minister and head of the Food and Drugs Administration.
The two sides discussed expansion of relations in healthcare technology and Bosch investments in medical engineering and pharmaceutical products, IRNA reported.
Bosch has an annual turnover of $200 billion. In addition to automotive components which generate around 60% of its revenue, the company manufactures industrial machinery for producing drugs and medical appliances. The latter is of interest to Iran’s healthcare system, said Asadi-Lari.
German Foreign Minister Frank-Walter Steinmeier’s during his recent visit to Tehran had said, “Berlin will encourage and lend support to German companies that are keen to invest in Iran.”
Bosch is likely to open its business office in Iran by next month. Touban, accompanied by a delegation of machinery specialists will visit early November to discuss further details of the collaboration, Asadi-Lari said.
“In particular, we discussed investments in installing packaging lines as well as manufacturing machinery to develop and produce vaccines, insulin and other drugs, and medical tools.”
Dinarvand welcomed a suggestion to hold a symposium by the end of the current Iranian year (March, 20, 2016) where along with Bosch officials, Iranian manufacturers of medical tools and pharmaceutical products would take part.
